Ultragenyx Pharmaceutical (RARE) EPS (Basic) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95% |
| Dec 31, 2025 | -28.17% |
| Sep 30, 2025 | -9.88% |
| Jun 30, 2025 | -36.77% |
| Mar 31, 2025 | 5.20% |
| Dec 31, 2024 | 3.16% |
| Sep 30, 2024 | 6.51% |
| Jun 30, 2024 | 2.44% |
| Mar 31, 2024 | -2.21% |
| Dec 31, 2023 | 3.60% |
| Sep 30, 2023 | -5.09% |
| Jun 30, 2023 | -16.25% |
| Mar 31, 2023 | -41.63% |
| Dec 31, 2022 | -2.71% |
| Sep 30, 2022 | -13.36% |
| Jun 30, 2022 | -5.61% |
| Mar 31, 2022 | -6.08% |
| Dec 31, 2021 | -0.45% |
| Sep 30, 2021 | 8.02% |
| Jun 30, 2021 | -4.39% |
| Mar 31, 2021 | -8.50% |
| Dec 31, 2020 | 23.58% |
| Sep 30, 2020 | -1.87% |
| Jun 30, 2020 | 20.17% |
| Mar 31, 2020 | -26.61% |
| Dec 31, 2019 | -25.52% |
| Sep 30, 2019 | -31.42% |
| Jun 30, 2019 | -30.76% |
| Mar 31, 2019 | -16.45% |
| Dec 31, 2018 | 19.06% |
| Sep 30, 2018 | 12.94% |
| Jun 30, 2018 | 20.41% |
| Mar 31, 2018 | 17.31% |